Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome.
暂无分享,去创建一个
S. Emans | C. Gordon | R. Legro | A. Dunaif | M. Palmert | A. Kartashov | S. Emans
[1] R. Turner,et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.
[2] P. Raskin,et al. Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.
[3] T. Valle,et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.
[4] N. Cox,et al. Heritability of insulin secretion and insulin action in women with polycystic ovary syndrome and their first degree relatives. , 2001, The Journal of clinical endocrinology and metabolism.
[5] D. Ehrmann,et al. Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial. , 2001, The Journal of clinical endocrinology and metabolism.
[6] J. Nestler,et al. Insulin-lowering drugs in polycystic ovary syndrome. , 2001, Obstetrics and gynecology clinics of North America.
[7] S. Arslanian,et al. Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and beta-cell dysfunction and risk of cardiovascular disease. , 2001, The Journal of clinical endocrinology and metabolism.
[8] S. Arslanian,et al. Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome. , 2001, The Journal of pediatrics.
[9] J. Radziuk,et al. Insulin sensitivity and its measurement: structural commonalities among the methods. , 2000, The Journal of clinical endocrinology and metabolism.
[10] F. de Zegher,et al. Sensitization to insulin in adolescent girls to normalize hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism after precocious pubarche. , 2000, The Journal of clinical endocrinology and metabolism.
[11] S. Oberfield. Metabolic lessons from the study of young adolescents with polycystic ovary syndrome--is insulin, indeed, the culprit? , 2000, The Journal of clinical endocrinology and metabolism.
[12] L. Groop,et al. Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study. , 2000, Diabetes.
[13] C. Solomon,et al. The epidemiology of polycystic ovary syndrome. Prevalence and associated disease risks. , 1999, Endocrinology and metabolism clinics of North America.
[14] A. Dunaif. Insulin action in the polycystic ovary syndrome. , 1999, Endocrinology and metabolism clinics of North America.
[15] P. Saenger,et al. The roles of insulin sensitivity, insulin-like growth factor I (IGF-I), and IGF-binding protein-1 and -3 in the hyperandrogenism of African-American and Caribbean Hispanic girls with premature adrenarche. , 1999, The Journal of clinical endocrinology and metabolism.
[16] R. Lobo,et al. Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. , 1999, The Journal of clinical endocrinology and metabolism.
[17] C. Gordon. Menstrual disorders in adolescents. Excess androgens and the polycystic ovary syndrome. , 1999, Pediatric clinics of North America.
[18] R. Rosenfield. Ovarian and adrenal function in polycystic ovary syndrome. , 1999, Endocrinology and metabolism clinics of North America.
[19] B. Sobel,et al. Cardiovascular consequences of polycystic ovary syndrome. , 1999, Endocrinology and metabolism clinics of North America.
[20] J. Marshall,et al. Neuroendocrine aspects of polycystic ovary syndrome. , 1999, Endocrinology and metabolism clinics of North America.
[21] D. Ehrmann. Insulin-lowering therapeutic modalities for polycystic ovary syndrome. , 1999, Endocrinology and metabolism clinics of North America.
[22] M. Cavaghan,et al. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. , 1999, Diabetes care.
[23] W. Dodson,et al. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. , 1999, The Journal of clinical endocrinology and metabolism.
[24] A. Taylor,et al. Understanding the underlying metabolic abnormalities of polycystic ovary syndrome and their implications. , 1998, American journal of obstetrics and gynecology.
[25] T. Key,et al. Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study* , 2022 .
[26] D. Finegood,et al. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. , 1998, The Journal of clinical endocrinology and metabolism.
[27] J. Hall,et al. Use of a gonadotropin-releasing hormone antagonist as a physiologic probe in polycystic ovary syndrome: assessment of neuroendocrine and androgen dynamics. , 1998, The Journal of clinical endocrinology and metabolism.
[28] K. Flegal,et al. Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994 , 1998, Diabetes Care.
[29] A. Dunaif,et al. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. , 1997, Endocrine reviews.
[30] S. Haffner,et al. The Homeostasis Model in the San Antonio Heart Study , 1997, Diabetes Care.
[31] J. Nestler. Role of Hyperinsulinemia in the Pathogenesis of the Polycystic Ovary Syndrome, and Its Clinical Implications , 1997, Seminars in reproductive endocrinology.
[32] D. Apter,et al. Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism. , 1995, The Journal of clinical endocrinology and metabolism.
[33] M. Zweig,et al. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. , 1993, Clinical chemistry.
[34] W. Tamborlane,et al. Insulin resistance of puberty: a defect restricted to peripheral glucose metabolism. , 1991, The Journal of clinical endocrinology and metabolism.
[35] K. Segal,et al. Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome , 1989, Diabetes.
[36] C. Bloch,et al. Puberty decreases insulin sensitivity. , 1987, The Journal of pediatrics.
[37] W. Tamborlane,et al. Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes. , 1986, The New England journal of medicine.
[38] C. Metz. Basic principles of ROC analysis. , 1978, Seminars in nuclear medicine.
[39] D. Ferriman,et al. Clinical assessment of body hair growth in women. , 1961, The Journal of clinical endocrinology and metabolism.